mRNA Vaccine and Therapeutics Market Growth

mRNA Vaccine and Therapeutics Market Growth is anticipated at a CAGR of 16% during the period 2026-2035

 

According to a recently published report by Roots Analysis, the increased investment in research and development of mRNA-based drugs, along with growing interest of drug developers in personalized medicine is driving the market growth 

mRNA Vaccine and Therapeutics Industry Overview

The global mRNA vaccine and therapeutics market size for non-COVID 19 indications is projected to be USD 1.99 billion by 2035, representing a CAGR of 16% during the forecast period, 2026-2035.

mRNA-based drugs have emerged as powerful and versatile tools, with mRNA vaccines demonstrating potent efficacy against infectious diseases and the rapid development of mRNA-based COVID-19 vaccines being a major milestone. Moreover, mRNA-based drugs offer flexibility by mediating transient therapeutic protein expression without genomic integration. However, challenges around effective delivery, translation, and immunogenicity must be addressed. mRNA therapeutics are also being explored for diverse applications, leveraging the ability to rapidly design and manufacture these drugs, and ongoing research aims to further optimize mRNA technology to unlock its full potential and revolutionize treatment of many currently incurable diseases.

The 270+ pages report contains detailed Table of Content on “mRNA Vaccine and Therapeutics Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Application Area, Target Disease Indication and Geographical Regions” here: https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html

Market Drivers 

The surge in mRNA vaccine development and adoption is driven by various factors, including rapid response capabilities, versatility for targeting various diseases and the success of COVID-19 vaccines. Additionally, advancements in lipid nanoparticle delivery systems have enhanced mRNA stability and efficacy, which has further propelled the widespread adoption of mRNA-based products. 

Market Restraints 

While the mRNA vaccines and therapeutics market has seen rapid growth, there are certain restraints that can potentially hinder the growth of the industry. Challenges in scaling up manufacturing, establishing robust regulatory frameworks, and further documenting long-term safety profiles may limit the pace of market expansion. Additionally, the high costs associated with developing and producing mRNA-based medicines can hinder broader accessibility.

Growth Factors

Given the challenges, several factors contribute to the growth of mRNA vaccine and therapeutics market. The growing investments in mRNA research and development by biotech firms, research institutions and pharmaceutical companies have been a key factor driving the growth of the mRNA vaccine and therapeutics market. Additionally, the versatility and efficacy of mRNA-based approaches, which enable the development of tailored treatments for a wide range of diseases is further propelling the demand for mRNA-based drugs.

mRNA Vaccine and Therapeutics Market Segments 

Based on the application area, the market is segmented into covid-19 and other indications

• The mRNA drug candidates developed for covid-19 has captured the majority share in mRNA vaccine and therapeutics market.

Based on the target disease indication, the market is segmented into influenza, respiratory syncytial virus infection and cytomegalovirus diseases

• mRNA drug candidates developed for respiratory syncytial virus infection is likely to dominate the market, capturing 40% of the overall share by 2035.
• The mRNA drug candidates developed for respiratory syncytial virus infection is expected to grow at a higher CAGR of 31%, during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Rest of the World

• North America will dominate the mRNA vaccine and therapeutics market, capturing 90% of the overall market share by 2035.

Key Companies Profiled 

The mRNA vaccine and therapeutics market report also includes profiles of key players (listed below) that are engaged in the development of mRNA vaccine and therapeutics:

• Arcturus Therapeutics
• BioNTech
• CureVac
• Ethris
• IMMORNA
• Moderna
• Providence Therapeutics
• RNACure
• Suzhou Abogen Biosciences
• Turn Biotechnologies
• Gennova
• Innovac Therapeutics
• Kernal Biologics
• Pantherna Therapeutics
• pHion Therapeutics
• Recode Therapeutics
• Rejuvenation Technologies
• RNAimmune
• Strand Therapeutics
• Walvax
• Ziphius Vaccines

You can download free sample PDF copy of this report at:
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com